There are 2789 resources available
449P - Homologous recombination repair gene mutations predict the efficacy of immune checkpoint inhibitors therapy in colorectal cancer
Presenter: Yan Lin
Session: ePoster Display
450P - Efficacy and safety of pyrotinib-based therapy in HER2-positive metastatic colorectal and gastric cancer: A retrospective study
Presenter: qian Li
Session: ePoster Display
452P - Predicting response to bevacizumab in colorectal cancer by integrating radiomics to clinical and genomic features
Presenter: Gianluca Milanese
Session: ePoster Display
453P - Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centre
Presenter: David Lau
Session: ePoster Display
331TiP - HER2CLIMB-04: Phase II trial of tucatinib + trastuzumab deruxtecan in patients with HER2+ locally advanced or metastatic breast cancer with and without brain metastases
Presenter: Lisa Carey
Session: ePoster Display
333TiP - AMEERA-1: Phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with alpelisib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) PIK3CA-mutated advanced breast cancer
Presenter: Mario Campone
Session: ePoster Display
334TiP - A phase I trial of niraparib plus anlotinib in advanced solid tumors with homologous recombination repair (HRR) gene mutations
Presenter: Jiayang Zhang
Session: ePoster Display
356P - Redo surgery in relapsed glioblastoma multiforme: A comparative cohort analysis of a single institution experience
Presenter: Selvaraj Giridharan
Session: ePoster Display